Back to results
US 2024/0181010 A1Published application
Uses of il-12 as a replacement immunotherapeutic
AssigneeNeumedicines, Inc.
InventorLena A. BASILE
Life of this patent
Estimating the term…
Abstract
Aspects and embodiments of the present disclosure provide therapeutic methods comprising interleukin 12 (IL-12) as a replacement immunotherapeutic. The method comprises administering a physiological dose of exogenous IL-12 to a subject.
Claims24
A method of administering IL-12 as a replacement immunotherapeutic comprising:
- (a) identifying a subject in need, wherein the subject is suffering from a disease or wound resulting in suppression of endogenous IL-12 expression;
- and
- (b) administering one or more physiological doses of exogenous IL-12 to the subject.
Dependencies are inferred from the claim text.